Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |